SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-098859
Filing Date
2022-04-07
Accepted
2022-04-07 16:05:58
Documents
8
Period of Report
2022-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d462323ddef14a.htm DEF 14A 437093
2 GRAPHIC g462323dsp013a.jpg GRAPHIC 2779
3 GRAPHIC g462323dsp013b.jpg GRAPHIC 1044
4 GRAPHIC g462323dsp013c.jpg GRAPHIC 912
5 GRAPHIC g462323dsp013d.jpg GRAPHIC 1414
6 GRAPHIC g462323dsp014a.jpg GRAPHIC 1118
7 GRAPHIC g462323dsp014b.jpg GRAPHIC 1081
8 GRAPHIC g462323g45n45.jpg GRAPHIC 63354
  Complete submission text file 0001193125-22-098859.txt   537910
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39512 | Film No.: 22813902
SIC: 2834 Pharmaceutical Preparations